Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
about
The role of HPV in head and neck cancer and review of the HPV vaccineThe forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapyCorrelation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic reviewLessons learned from next-generation sequencing in head and neck cancerAn updated overview of HPV-associated head and neck carcinomasIs radiation dose reduction the right answer for HPV-positive head and neck cancer?Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysisHPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapyHuman papillomavirus and gastrointestinal cancer: A reviewHuman papillomavirus-related esophageal cancer survival: A systematic review and meta-analysisManagement of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy.Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma.Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer.Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomasRefining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.Counseling the patient with potentially HPV-related newly diagnosed head and neck cancerAn examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies.Designing biomarker studies for head and neck cancer.Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerMeta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).Clinical and scientific impact of human papillomavirus on head and neck cancer.Human papillomavirus-associated oropharyngeal cancer: a new clinical entity.Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinomaImpact of HPV in Oropharyngeal Cancer.Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer.Human papillomavirus prevalence in invasive laryngeal cancer in the United StatesUnraveling the molecular genetics of head and neck cancer through genome-wide approachesThe association between human papillomavirus 16 and esophageal cancer in Chinese population: a meta-analysis.Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials.The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV)
P2860
Q24630128-4612CEC6-9C45-47A5-AFFA-14F825B99A08Q26744087-84EEA982-0A5F-44F4-B3A0-97200E87F1B2Q26824273-F40E0D47-3F49-4EC7-85DC-3D2D35959BE0Q27009209-E6018A23-C8E8-48F0-8800-FED76E679B3EQ27014019-BB4647FB-F677-4BC6-B676-113EEA6980CCQ27024764-7ABDB8FE-E327-4ED4-99E5-32CCB84E2BE5Q27027842-9C33C0DA-D9EF-45B3-8DD6-A9DD56817CD1Q27852254-68427E55-09A9-40F1-A82A-BEFA66504771Q27852901-BCADDA17-0DFB-4703-A646-33E12E369692Q28069930-5CA09334-F006-4A6E-90E8-0878E8A8312FQ30241058-4672899D-D8C1-4984-8411-1E0D6AC537F9Q30252081-62F64F35-C351-4223-8C20-ABA0E48B76EEQ30425570-7ADA693D-7D34-449A-B04B-13290584B1DDQ30428813-B4452DE0-16CA-4C1A-B967-A9F0DDF060C7Q33702362-012AD231-5003-4F39-9EB1-2CB434104C38Q33736889-E3A1C2F3-DFEE-49AA-93D4-1069883C39C7Q33798441-6BA909C7-013B-4B51-8067-4FD779626580Q33846990-F5C69D2E-8A76-482A-A303-D2DCF6E19C16Q33863850-8D9AF79F-7D3A-4E8A-92B5-40EED33C8003Q33908473-5FBD2622-CB19-40C0-9368-4070EF1606B5Q33957013-445DA715-4672-44D1-A66B-F58A6D6BDD00Q33971467-5BBCC320-2C31-4733-97B1-EC8F7A4459B3Q33986942-BC8B7D1B-7733-4249-BF05-26C9247C7202Q34011808-00F1331C-2D7F-4EB4-9BEE-68D1E5536E96Q34031281-BFF45F2F-5058-4651-9C00-8063C21C9382Q34088512-9C7402A5-0F86-4B14-91AE-377397AB42CDQ34193953-9471689D-C66E-4104-84F5-0FFE415EC963Q34462878-10EE8553-E0E0-4E31-8FA7-473CD968A0CAQ34479115-4E2D066C-DD5B-43DD-B566-10918E78DEA7Q34547715-EBA3B577-130D-466B-BF14-6592086355A3Q34554185-AD78EB7B-9B7B-491C-946D-8B6D94BDA06AQ34768545-CF18D974-1423-450F-A50B-B8111F23ED18Q34784302-4FF0583E-7FEB-4911-995E-89F890BAEB7FQ35025009-A16AC7C8-04AF-4EC9-A54C-9A02414305D2Q35155384-CE875C44-1104-4905-8D27-DD1BEB7B5B8FQ35174609-89E9A2FE-7DB4-43C3-82A4-4681E53161ABQ35207399-70146483-084B-4893-9074-ECE64B46D308Q35344832-9F46015B-5BF0-4F6C-A6C4-A399E19CAC4FQ35475603-EB4CA2A5-3AD1-4AF6-BBA2-EAA7D23040BFQ35533867-425A38B9-F8B2-4CD3-A689-B60B6D39604A
P2860
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@en
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@nl
type
label
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@en
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@nl
prefLabel
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@en
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@nl
P2093
P2860
P356
P1476
Combined analysis of HPV-DNA, ...... nosis in oropharyngeal cancer.
@en
P2093
Ernst Jan M Speel
Hans P Dienes
Hans U Kasper
Hartmut Stützer
Herbert J Pfister
Jens P Klussmann
Niklas Reimers
Simon F Preuss
Soenke J Weissenborn
Thomas K Hoffmann
P2860
P304
P356
10.1002/IJC.22355
P577
2007-04-01T00:00:00Z